Patent holder - Mr.Nikolay Tereshchenko
   Phone: (0162)23-03-15
   Fax:   (0162)26-62-20, 32-04-15
   Address: Ul.Kuibisheva, 40, apt.72
           City of Brest-16, Republic Belarus

   Russian Technologies (KNOW-HOW)

   Patent of Russia

   Subject: Lactic Acid Bacteria Consortium "TNN-92"
            Trade mark "TONARIN"

     Tonarine -  is a consortium  of lactic acid bacteria  cultures  "TNN-92"
designed to produce bacterial  and sour dairy preparations.  It is indicated
for prophylactic nutrition and  treatment of both childred  and {*filter*}s having
functional  disorders, infflamatory conditions in alimentary canal,intestinal
infections  intestinal  dysbacteriosis,  bacillicarrier  condition  and other
diseases.  It is a substitute for  {*filter*} milk, removes  radionuclides out of
organism and produces Interferon (according to studies of Japanese researchers
of the Pasteur Institute of Kioto, Japan). The Health Ministry of the Russian
Federation  have  issued  administration  instructions.  By  its  therapeutic
properties Tonarin is more effective & will  khown Narime  which the Japanese
bought in 1986 at 1000000 US$ under the Licence Agreement N 7311/098613 dated
19.08.96. With Licenseintorg, Moscow for the period of 5 years. Production of
Tonarin is not complicated. Specifications, production  technology  and trade
mark are avialable. The culture is registeres  in  the  ALL-Russia Scientific
and Research Institute of Genetics,Moscow.The production is highly profitable.
I am looking for producers,shall provide the license only to serious companies
on a competitative bases. "Tanarin" can be effectively used in the production
of bacterial preparations and baby food.
   "Tanarin"  has antibiotic  activity  toward  Escherichia  coli,  Schigella
Flexneri, staphylococcus, salmonella.  It  is  tolerant  to such  widely used
antibiotics as benzylpenicillin,  levomicitine,  tetracycline  and  to phenol,
NaCI, bile as well. It is steadily maintained in human body. The patent search
has showm that it has no analogy in the world.  The  starting  price  of  the
license is MCD 1,500,000. A shall offer the license on preferential terms.
   "Tanarin" will find wide application in hot  climate  countries  with  high
risk of outbreaks of gastrointestinal infections epidemics.  Clinic tests have
shown that "Tanarin" can be  used  with  success  while  treating  inflamatory
processes of lungs and  urino-{*filter*}  system,  diabetes,  paradantos,  female
disorders. "Tonarin"  supresses  growth  of  enterobacteria,  pathogenic
staphylococcus,  roises activity of normal  Escherchia coli, removes gemolitic
and lactosedefective form of Escherichia coli.
   "Tonarin" can be  used as an  addional  baky  food  for infants,  including
prematurely born, weakened,  born  by  mothers  with Rhesus-negative of with a
lower content of haemoglobin in  {*filter*}.  Contra-indication  to application  of
Tanaric has not been found.
   I am looking for partners  interested in production of medical prepatations
and baby food.

   Best regard,

                                      Nicolay Tereshchenko